TY - JOUR AU - Reichardt, P. PY - 2009 DA - 2009// TI - Gastrointestinal stromal tumors I: pathology, pathobiology, primary therapy, and surgical issues JO - Semin Oncol VL - 36 UR - https://doi.org/10.1053/j.seminoncol.2009.06.002 DO - 10.1053/j.seminoncol.2009.06.002 ID - Reichardt2009 ER - TY - JOUR AU - Liegl-Atzwanger, B. AU - Fletcher, J. A. AU - Fletcher, C. D. PY - 2010 DA - 2010// TI - Gastrointestinal stromal tumors JO - Virchows Arch VL - 456 UR - https://doi.org/10.1007/s00428-010-0891-y DO - 10.1007/s00428-010-0891-y ID - Liegl-Atzwanger2010 ER - TY - JOUR AU - Agaram, N. P. PY - 2008 DA - 2008// TI - Novel V600E BRAF mutations in Imatinib-naive and Imatinib-resistant gastrointestinal stromal tumors JO - Genes Chrom Cancer VL - 47 UR - https://doi.org/10.1002/gcc.20589 DO - 10.1002/gcc.20589 ID - Agaram2008 ER - TY - JOUR PY - 2010 DA - 2010// TI - Comparison of two doses of Imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.24.2099 DO - 10.1200/JCO.2009.24.2099 ID - ref4 ER - TY - JOUR AU - Buchdunger, E. AU - O’Reilly, T. AU - Wood, J. PY - 2002 DA - 2002// TI - Pharmacology of Imatinib (STI571) JO - Eur J Cancer VL - 38 UR - https://doi.org/10.1016/S0959-8049(02)80600-1 DO - 10.1016/S0959-8049(02)80600-1 ID - Buchdunger2002 ER - TY - JOUR AU - Kingham, T. P. AU - DeMatteo, R. P. PY - 2009 DA - 2009// TI - Multidisciplinary treatment of gastrointestinal stromal tumors JO - Surg Clin North Am VL - 89 UR - https://doi.org/10.1016/j.suc.2008.10.003 DO - 10.1016/j.suc.2008.10.003 ID - Kingham2009 ER - TY - JOUR AU - Dematteo, R. P. PY - 2009 DA - 2009// TI - Adjuvant Imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial JO - Lancet VL - 373 UR - https://doi.org/10.1016/S0140-6736(09)60500-6 DO - 10.1016/S0140-6736(09)60500-6 ID - Dematteo2009 ER - TY - JOUR AU - Debiec-Rychter, M. PY - 2004 DA - 2004// TI - Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to Imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group JO - Eur J Cancer VL - 40 UR - https://doi.org/10.1016/j.ejca.2003.11.025 DO - 10.1016/j.ejca.2003.11.025 ID - Debiec-Rychter2004 ER - TY - JOUR AU - Heinrich, M. C. PY - 2006 DA - 2006// TI - Molecular correlates of Imatinib resistance in gastrointestinal stromal tumors JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2006.06.2265 DO - 10.1200/JCO.2006.06.2265 ID - Heinrich2006 ER - TY - JOUR AU - Agaram, N. P. PY - 2007 DA - 2007// TI - Pathologic and molecular heterogeneity in Imatinib-stable or Imatinib-responsive gastrointestinal stromal tumors JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-1508 DO - 10.1158/1078-0432.CCR-06-1508 ID - Agaram2007 ER - TY - JOUR AU - Prenen, H. PY - 2006 DA - 2006// TI - Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to Imatinib mesylate JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-2275 DO - 10.1158/1078-0432.CCR-05-2275 ID - Prenen2006 ER - TY - JOUR AU - Wardelmann, E. PY - 2006 DA - 2006// TI - Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with Imatinib mesylate JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-1211 DO - 10.1158/1078-0432.CCR-05-1211 ID - Wardelmann2006 ER - TY - JOUR AU - Demetri, G. D. PY - 2006 DA - 2006// TI - Efficacy and safety of Sunitinib in patients with advanced gastrointestinal stromal tumour after failure of Imatinib: a randomised controlled trial JO - Lancet VL - 368 UR - https://doi.org/10.1016/S0140-6736(06)69446-4 DO - 10.1016/S0140-6736(06)69446-4 ID - Demetri2006 ER - TY - JOUR AU - George, S. PY - 2009 DA - 2009// TI - Clinical evaluation of continuous daily dosing of Sunitinib malate in patients with advanced gastrointestinal stromal tumour after Imatinib failure JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2009.02.011 DO - 10.1016/j.ejca.2009.02.011 ID - George2009 ER - TY - JOUR AU - Trent, J. C. PY - 2011 DA - 2011// TI - A Phase II study of dasatinib for patients with Imatinib-resistant gastrointestinal stromal tumor (GIST) JO - J Clin Oncol VL - I ID - Trent2011 ER - TY - JOUR AU - George, S. PY - 2011 DA - 2011// TI - A multicenter phase II study of regorafenib in patients (pts) with advanced gastrointestinal stromal tumor (GIST), after therapy with Imatinib (IM) and sunitinib (SU) JO - J Clin Oncol VL - I ID - George2011 ER - TY - JOUR AU - Demetri, G. D. PY - 2012 DA - 2012// TI - Randomized phase III trial of regorafenib in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) progressing despite prior treatment with at least Imatinib (IM) and sunitinib (SU): GRID trial JO - J Clin Oncol VL - 30 ID - Demetri2012 ER - TY - JOUR AU - Corless, C. L. AU - Barnett, C. M. AU - Heinrich, M. C. PY - 2011 DA - 2011// TI - Gastrointestinal stromal tumours: origin and molecular oncology JO - Nat Rev Cancer VL - 11 ID - Corless2011 ER - TY - JOUR AU - Taguchi, T. PY - 2002 DA - 2002// TI - Conventional and molecular cytogenetic characterization of a new human cell line, GIST-T1, established from gastrointestinal stromal tumor JO - Lab Invest J Tech Methods Pathol VL - 82 UR - https://doi.org/10.1038/labinvest.3780461 DO - 10.1038/labinvest.3780461 ID - Taguchi2002 ER - TY - JOUR AU - Tuveson, D. A. PY - 2001 DA - 2001// TI - STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications JO - Oncogene VL - 20 UR - https://doi.org/10.1038/sj.onc.1204704 DO - 10.1038/sj.onc.1204704 ID - Tuveson2001 ER - TY - JOUR AU - Prenen, H. PY - 2006 DA - 2006// TI - Establishment of a mouse gastrointestinal stromal tumour model and evaluation of response to Imatinib by small animal positron emission tomography JO - Anticancer Res VL - 26 ID - Prenen2006 ER - TY - JOUR AU - Huynh, H. PY - 2009 DA - 2009// TI - Sorafenib induces growth suppression in mouse models of gastrointestinal stromal tumor JO - Mol Cancer Therap VL - 8 UR - https://doi.org/10.1158/1535-7163.MCT-08-0553 DO - 10.1158/1535-7163.MCT-08-0553 ID - Huynh2009 ER - TY - JOUR AU - Wang, T. B. AU - Huang, W. S. AU - Lin, W. H. AU - Shi, H. P. AU - Dong, W. G. PY - 2010 DA - 2010// TI - Inhibition of KIT RNAi mediated with adenovirus in gastrointestinal stromal tumor xenograft JO - World J Gastroenterol: WJG VL - 16 UR - https://doi.org/10.3748/wjg.v16.i40.5122 DO - 10.3748/wjg.v16.i40.5122 ID - Wang2010 ER - TY - JOUR AU - Rubin, B. P. PY - 2005 DA - 2005// TI - A knock-in mouse model of gastrointestinal stromal tumor harboring kit K641E JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-0891 DO - 10.1158/0008-5472.CAN-05-0891 ID - Rubin2005 ER - TY - JOUR AU - Sommer, G. PY - 2003 DA - 2003// TI - Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase JO - Proc Natl Acad Sci USA VL - 100 UR - https://doi.org/10.1073/pnas.1037763100 DO - 10.1073/pnas.1037763100 ID - Sommer2003 ER - TY - JOUR AU - Shultz, L. D. AU - Ishikawa, F. AU - Greiner, D. L. PY - 2007 DA - 2007// TI - Humanized mice in translational biomedical research JO - Nat Rev Immunol VL - 7 UR - https://doi.org/10.1038/nri2017 DO - 10.1038/nri2017 ID - Shultz2007 ER - TY - JOUR AU - Ishikawa, F. PY - 2005 DA - 2005// TI - Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chain(null) mice JO - Blood VL - 106 UR - https://doi.org/10.1182/blood-2005-02-0516 DO - 10.1182/blood-2005-02-0516 ID - Ishikawa2005 ER - TY - JOUR AU - Shultz, L. D. PY - 2005 DA - 2005// TI - Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells JO - J Immunol VL - 174 UR - https://doi.org/10.4049/jimmunol.174.10.6477 DO - 10.4049/jimmunol.174.10.6477 ID - Shultz2005 ER - TY - JOUR AU - Quintana, E. PY - 2008 DA - 2008// TI - Efficient tumour formation by single human melanoma cells JO - Nature VL - 456 UR - https://doi.org/10.1038/nature07567 DO - 10.1038/nature07567 ID - Quintana2008 ER - TY - JOUR AU - King, M. PY - 2008 DA - 2008// TI - A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene JO - Clin Immunol VL - 126 UR - https://doi.org/10.1016/j.clim.2007.11.001 DO - 10.1016/j.clim.2007.11.001 ID - King2008 ER - TY - JOUR AU - Simpson-Abelson, M. R. PY - 2008 DA - 2008// TI - Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice JO - J Immunol VL - 180 UR - https://doi.org/10.4049/jimmunol.180.10.7009 DO - 10.4049/jimmunol.180.10.7009 ID - Simpson-Abelson2008 ER - TY - JOUR AU - Feldman, J. AU - Goldwasser, R. AU - Mark, S. AU - Schwartz, J. AU - Orion, I. PY - 2009 DA - 2009// TI - A mathematical model for tumor volume evaluation using two-dimensions JO - J Appl Quant Methods VL - 4 ID - Feldman2009 ER - TY - JOUR AU - Edris, B. PY - 2013 DA - 2013// TI - Anti-KIT monoclonal antibody inhibits Imatinib-resistant gastrointestinal stromal tumor growth JO - Proc Natl Acad Sci USA VL - 110 UR - https://doi.org/10.1073/pnas.1222893110 DO - 10.1073/pnas.1222893110 ID - Edris2013 ER - TY - JOUR AU - Reynolds, C. P. AU - Sun, B. C. AU - DeClerck, Y. A. AU - Moats, R. A. PY - 2005 DA - 2005// TI - Assessing growth and response to therapy in murine tumor models JO - Methods Mol Med VL - 111 ID - Reynolds2005 ER - TY - JOUR AU - Huynh, A. S. PY - 2011 DA - 2011// TI - Development of an orthotopic human pancreatic cancer xenograft model using ultrasound guided injection of cells JO - PloS one VL - 6 UR - https://doi.org/10.1371/journal.pone.0020330 DO - 10.1371/journal.pone.0020330 ID - Huynh2011 ER - TY - JOUR AU - Killion, J. J. AU - Radinsky, R. AU - Fidler, I. J. PY - 1998 DA - 1998// TI - Orthotopic models are necessary to predict therapy of transplantable tumors in mice JO - Cancer Metast Rev VL - 17 UR - https://doi.org/10.1023/A:1006140513233 DO - 10.1023/A:1006140513233 ID - Killion1998 ER - TY - JOUR AU - Revheim, M. E. PY - 2013 DA - 2013// TI - Intermittent and continuous Imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H JO - Acta Oncol VL - 52 UR - https://doi.org/10.3109/0284186X.2013.770920 DO - 10.3109/0284186X.2013.770920 ID - Revheim2013 ER - TY - JOUR AU - Moriyama, M. PY - 2013 DA - 2013// TI - Establishment and characterization of a novel xenograft model of human gastrointestinal stromal tumor in mice JO - Anticancer Res VL - 33 ID - Moriyama2013 ER - TY - JOUR AU - Richmond, A. AU - Su, Y. PY - 2008 DA - 2008// TI - Mouse xenograft models vs GEM models for human cancer therapeutics JO - Dis Models Mechan VL - 1 UR - https://doi.org/10.1242/dmm.000976 DO - 10.1242/dmm.000976 ID - Richmond2008 ER - TY - JOUR AU - Morioka, C. Y. AU - Saito, S. AU - Ohzawa, K. AU - Watanabe, A. PY - 2000 DA - 2000// TI - Homologous orthotopic implantation models of pancreatic ductal cancer in Syrian golden hamsters: which is better for metastasis research–cell implantation or tissue implantation? JO - Pancreas VL - 20 UR - https://doi.org/10.1097/00006676-200003000-00007 DO - 10.1097/00006676-200003000-00007 ID - Morioka2000 ER - TY - JOUR AU - Sicklick, J. K. AU - Lopez, N. E. PY - 2013 DA - 2013// TI - Optimizing surgical and Imatinib therapy for the treatment of gastrointestinal stromal tumors JO - J Gastroint Surg VL - 17 UR - https://doi.org/10.1007/s11605-013-2243-0 DO - 10.1007/s11605-013-2243-0 ID - Sicklick2013 ER - TY - JOUR AU - Hidalgo, M. PY - 2011 DA - 2011// TI - A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer JO - Mol Cancer Therap VL - 10 UR - https://doi.org/10.1158/1535-7163.MCT-11-0233 DO - 10.1158/1535-7163.MCT-11-0233 ID - Hidalgo2011 ER - TY - JOUR AU - Moro, M. PY - 2012 DA - 2012// TI - Patient-derived xenografts of non small cell lung cancer: resurgence of an old model for investigation of modern concepts of tailored therapy and cancer stem cells JO - J Biomed Biotechnol VL - 2012 UR - https://doi.org/10.1155/2012/568567 DO - 10.1155/2012/568567 ID - Moro2012 ER - TY - JOUR AU - Revheim, M. E. PY - 2009 DA - 2009// TI - Establishment and characterization of a human gastrointestinal stromal tumour (GIST) xenograft in athymic nude mice JO - Anticancer Res VL - 29 ID - Revheim2009 ER -